Livforsakringsbolaget Skandia Omsesidigt Sells 25,900 Shares of Oracle Co. (NYSE:ORCL)

Livforsakringsbolaget Skandia Omsesidigt reduced its stake in Oracle Co. (NYSE:ORCL - Free Report) by 18.3% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 115,388 shares of the enterprise software provider's stock after selling 25,900 shares during the period. Oracle accounts for 0.9% of Livforsakringsbolaget Skandia Omsesidigt's portfolio, making the stock its 18th largest position. Livforsakringsbolaget Skandia Omsesidigt's holdings in Oracle were worth $16,131,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds also recently made changes to their positions in the company. Capital & Planning LLC boosted its stake in Oracle by 0.5% during the 4th quarter. Capital & Planning LLC now owns 15,727 shares of the enterprise software provider's stock valued at $2,621,000 after purchasing an additional 81 shares during the last quarter. Brighton Jones LLC increased its holdings in Oracle by 189.3% in the 4th quarter. Brighton Jones LLC now owns 153,580 shares of the enterprise software provider's stock worth $25,593,000 after buying an additional 100,494 shares in the last quarter. Union Bancaire Privee UBP SA bought a new position in Oracle during the fourth quarter valued at approximately $51,084,000. Revolve Wealth Partners LLC boosted its stake in shares of Oracle by 8.1% in the 4th quarter. Revolve Wealth Partners LLC now owns 5,418 shares of the enterprise software provider's stock worth $903,000 after buying an additional 404 shares during the last quarter. Finally, Entropy Technologies LP bought a new stake in shares of Oracle in the fourth quarter worth $2,304,000. 42.44% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on ORCL. Cantor Fitzgerald dropped their target price on Oracle from $214.00 to $175.00 and set an "overweight" rating on the stock in a research report on Tuesday, March 11th. Wall Street Zen lowered shares of Oracle from a "buy" rating to a "hold" rating in a research report on Wednesday, February 19th. Stifel Nicolaus decreased their price target on shares of Oracle from $175.00 to $150.00 and set a "hold" rating on the stock in a research report on Tuesday, March 11th. Monness Crespi & Hardt raised shares of Oracle from a "sell" rating to a "neutral" rating in a research report on Monday, March 3rd. Finally, Evercore ISI reduced their price objective on Oracle from $200.00 to $185.00 and set an "outperform" rating for the company in a research note on Tuesday, March 11th. Thirteen equities research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, Oracle has a consensus rating of "Moderate Buy" and a consensus price target of $177.35.

Insider Activity

In other Oracle news, Director Naomi O. Seligman sold 2,866 shares of the firm's stock in a transaction dated Monday, May 5th. The shares were sold at an average price of $149.53, for a total transaction of $428,552.98. Following the transaction, the director now owns 31,764 shares of the company's stock, valued at approximately $4,749,670.92. This trade represents a 8.28% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Leon E. Panetta sold 17,500 shares of the company's stock in a transaction that occurred on Friday, May 2nd. The stock was sold at an average price of $151.24, for a total transaction of $2,646,700.00. Following the completion of the sale, the director now directly owns 58,090 shares of the company's stock, valued at $8,785,531.60. The trade was a 23.15% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 27,366 shares of company stock valued at $4,015,723. 42.20% of the stock is currently owned by insiders.

Oracle Trading Up 0.3%

Shares of NYSE:ORCL traded up $0.46 during trading on Tuesday, reaching $177.61. The company's stock had a trading volume of 11,039,682 shares, compared to its average volume of 9,517,058. The stock has a market capitalization of $496.77 billion, a PE ratio of 43.43, a price-to-earnings-growth ratio of 3.46 and a beta of 1.32. Oracle Co. has a 12 month low of $118.86 and a 12 month high of $198.31. The company has a current ratio of 0.81, a quick ratio of 0.81 and a debt-to-equity ratio of 5.65. The firm's 50 day simple moving average is $147.83 and its two-hundred day simple moving average is $160.13.

Oracle (NYSE:ORCL - Get Free Report) last announced its earnings results on Monday, March 10th. The enterprise software provider reported $1.47 EPS for the quarter, missing analysts' consensus estimates of $1.49 by ($0.02). The company had revenue of $14.13 billion during the quarter, compared to analysts' expectations of $14.40 billion. Oracle had a return on equity of 133.25% and a net margin of 21.16%. Oracle's revenue for the quarter was up 6.4% compared to the same quarter last year. During the same quarter last year, the firm posted $1.41 EPS. On average, research analysts predict that Oracle Co. will post 5 EPS for the current fiscal year.

About Oracle

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.